BioDiem Ltd.
Level 10, The Atrium Building
459 Collins Street
Melbourne
Vic 3000
Tel: 61-3-9613-4100
Fax: 61-3-9613-4111
Website: http://www.biodiem.com/
Email: info@biodiem.com
34 articles about BioDiem Ltd.
-
BioDiem Ltd.'s Announcement Of Approval Of LAIV Seasonal Flu Vaccine In India
2/18/2014
-
BioDiem Ltd.'s BDM-I Presented at International Conference
9/16/2013
-
BioDiem Ltd. Release: Proof of Principle Shown in Liver Disease Vaccine Program
7/22/2013
-
BioDiem Ltd. Enhances Its Antimicrobial Program as it Completes Work With Griffith University
7/11/2013
-
New Japanese Protozoal Patent for BioDiem Ltd.'s BDM-I
5/22/2013
-
Van Leeuwenhoeck Research Publishes Updated BioDiem Ltd. Analyst Report
4/5/2013
-
BioDiem Ltd. Releases Half Year Results
2/21/2013
-
Additional Patent Granted in China for BioDiem Ltd.'s Antimicrobial
2/21/2013
-
BioDiem Ltd. Extends Co-Operative Agreement With USAMRIID
2/14/2013
-
BioDiem Ltd. Receives Early Annual License Fee From Chinese Partner
2/12/2013
-
BioDiem Ltd. Progresses to Proof-of-Concept Testing of BDM-I Antimicrobial Effect Against Parasites
2/8/2013
-
BioDiem Ltd.'s Antimicrobial Tested as Treatment for TB, Fungal Infections, in National Institutes of Health (NIH) Research Program
2/1/2013
-
Japanese Patent Office to Grant BioDiem Ltd. New Patent for BDM-I Antimicrobial
11/21/2012
-
BioDiem Ltd. Partners With Griffith University to Enhance Antimicrobial Drug
11/8/2012
-
BioDiem Ltd. Reports Continued Progress in Development of Antimicrobial BDM-I
10/18/2012
-
Successful Growth of BioDiem Ltd.'s Virus in VIVALIS EB66® Cell Line
8/21/2012
-
BioDiem Ltd. Granted European Patent for BDM-I Antimicrobial
8/7/2012
-
BioDiem Ltd. Presents Findings at International Eye Research Meeting
7/23/2012
-
BioDiem Ltd. Signs Agreement With Royal Melbourne Institute of Technology (RMIT) to Create New Non-influenza Vaccines
7/20/2012
-
BioDiem Ltd. Acquires Rights to Novel Hepatitis Vaccine Technology from University of Canberra
6/27/2012